Need to change present regulatory framework for blood banks in India
Year: 2011
Type: article
Abstract: There is continuous debate among blood bank personnel whether blood bank should come under the purview of the regulatory authority overseeing Food and Drug Administration (FDA). We, blood bankers (per se transfusion medicine specialists), want to justify this fact that it should be out of FDA purview because blood is not a drug but liquid tissue. This is a true statement. However, we should remember that all blood and blood components have medicinal values. For example, we expect a rise of 1 g% of hemoglobin after transfusion of every unit of whole blood or red blood cell. That is why blood banks will come under the regulatory purview of FDA for years to come as per specific regulation decided by the law of the land. We can see the same law applicable in many countries in the world to regulate blood bank industry.
Author: Nabajyoti Choudhury
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: diamond
OpenAlex ID: W2040322503